APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $26,005,000 | +23.6% | 411,471 | -16.1% | 3.07% | +53.4% |
| Q1 2021 | $21,046,000 | -25.0% | 490,471 | 0.0% | 2.00% | -19.2% |
| Q4 2020 | $28,055,000 | +85.4% | 490,471 | -2.2% | 2.48% | +7.7% |
| Q3 2020 | $15,133,000 | -7.6% | 501,584 | 0.0% | 2.30% | -83.1% |
| Q2 2020 | $16,382,000 | +21.9% | 501,584 | 0.0% | 13.62% | +19.0% |
| Q1 2020 | $13,437,000 | -56.1% | 501,584 | -49.8% | 11.45% | -12.8% |
| Q4 2019 | $30,620,000 | +27.1% | 1,000,000 | 0.0% | 13.13% | +14.9% |
| Q3 2019 | $24,090,000 | -4.9% | 1,000,000 | 0.0% | 11.43% | +1.6% |
| Q2 2019 | $25,340,000 | -14.8% | 1,000,000 | -34.5% | 11.24% | -53.3% |
| Q1 2019 | $29,759,000 | +26.0% | 1,526,122 | -14.7% | 24.10% | -61.1% |
| Q4 2018 | $23,611,000 | – | 1,790,102 | – | 62.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |